Serur, Yaffa
Fuhrmann, Naomi
Russo, Odeya
Green, Tamar
Funding for this research was provided by:
Postdoctoral Research Fellowship in Child & Adolescent Psychiatry supported by the Harvey L. and Maud C. Sorensen Foundation
National Institute of Child Health and Human Development (123752K23)
Stanford Maternal and Child Health Research Institute
Stephen Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine
Neurofibromatosis Therapeutic Acceleration Program at the John Hopkins University School of Medicine
Article History
Received: 11 November 2024
Accepted: 26 May 2025
First Online: 3 June 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, approved by the Stanford University School of Medicine Institutional Review Board, and followed during all study components. IRB Protocol # 57403, date of last approval: 09/03/2024.
: Informed consent was obtained from all subjects involved in the study. Parents or legal guardians provided informed written consent for their child’s participation in the study; participants over age 7 submitted an additional written assent.
: The authors declare no competing interests.